U.S. Semiconductors Stock News

NasdaqCM:HDSN
NasdaqCM:HDSNTrade Distributors

High Insider Ownership Growth Companies To Watch In September 2025

As September 2025 unfolds, the U.S. stock market is experiencing a turbulent start with significant declines in major indices like the Dow Jones and Nasdaq, largely driven by uncertainties in trade policies and tech sector volatility. Amidst this backdrop, identifying growth companies with high insider ownership can be an attractive strategy for investors seeking stability and potential upside, as these firms often exhibit strong alignment between management interests and shareholder value.
NasdaqGS:GEG
NasdaqGS:GEGCapital Markets

3 Promising Penny Stocks With Over $70M Market Cap

As the U.S. stock market experiences a downturn, with tech giants leading the decline and gold reaching new highs, investors are increasingly seeking alternative opportunities in less volatile sectors. Penny stocks, while often associated with smaller or newer companies, can offer unique growth potential when backed by solid financials and fundamentals. In this article, we explore three penny stocks that stand out for their financial strength and potential to deliver impressive returns amidst...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express (AXP): Assessing Valuation as New Sports Partnership Expands Premium Cardholder Benefits

Kshitija Bhandaru
American Express just made waves with a major partnership announcement, becoming the official payments partner at Hard Rock Stadium, the Miami Dolphins, and the Formula 1 Miami Grand Prix. This multi-year deal brings exclusive fan perks to eligible cardholders, from presale event tickets to dedicated lounges and entrances. For investors, this is not just marketing; it represents another step in Amex’s expansion of its global sports and entertainment footprint, aimed squarely at deepening...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer (PFE) Valuation in Focus Following FDA Approval of Updated COVID-19 Vaccine

Kshitija Bhandaru
Pfizer (PFE) just landed a significant regulatory win. On August 27, the company and its partner BioNTech announced that the U.S. Food and Drug Administration approved their updated LP.8.1-adapted monovalent COVID-19 vaccine. This new version is cleared for adults aged 65 and over, as well as younger high-risk individuals, thanks to clinical data showing it provides stronger immune protection against multiple newer COVID strains. For investors wondering where this leaves Pfizer as COVID...
NYSE:ABBV
NYSE:ABBVBiotechs

Assessing AbbVie (ABBV) Valuation Following New Clinical Trial Breakthroughs and Upward Earnings Revisions

Kshitija Bhandaru
If you own shares of AbbVie or have been watching from the sidelines, the latest wave of clinical trial results may have just put the stock back on your radar. AbbVie has made headlines with positive updates across a handful of key programs, including encouraging data from its pivotal Phase 3 trial of upadacitinib (RINVOQ) in severe alopecia areata as well as early-stage progress in multiple cancer therapies. These developments, paired with upwardly revised earnings estimates, are fueling a...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A): Examining Valuation as Buffett Hands CEO Role to Greg Abel

Kshitija Bhandaru
It is not every day that investors in Berkshire Hathaway (BRK.A) wake up to big news from Omaha. Today’s headline is hard to ignore. Warren Buffett, the titan who has steered the company for decades, will soon hand over the CEO reins to Greg Abel. The announcement that Buffett will step aside as CEO caught the market’s attention, raising questions about leadership, strategy, and what it all means for shareholders. While Buffett plans to remain as chairman, this marks a historic transition for...
NYSE:VFC
NYSE:VFCLuxury

V.F Corp (VFC): Assessing Valuation Following Analyst Upgrade and Renewed Optimism on Turnaround Prospects

Kshitija Bhandaru
V.F (VFC) just got a confidence boost, with Baird upgrading the stock based on signs of a turnaround in the Vans brand, better product momentum, and clear progress on cost-cutting and debt management. This nod from analysts seems to have brightened investor spirits, especially as it lines up with the company’s announced changes to its revolving credit facility, giving them more financial flexibility to support their transformation plans. For shareholders on the sidelines, it is the kind of...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Align Technology (ALGN) Valuation in Focus After Earnings Miss and Securities Investigation News

Kshitija Bhandaru
If you own or are eyeing shares of Align Technology (ALGN), the latest string of headlines is hard to ignore. The company’s release of its second-quarter 2025 results fell short of Wall Street expectations, and management trimmed its sales outlook for the rest of the year, citing persistent economic uncertainty and softer demand. In addition, news broke of a securities fraud investigation into Align’s leadership, adding a fresh layer of uncertainty for investors looking to gauge what comes...
NYSE:EPAM
NYSE:EPAMIT

EPAM Systems (EPAM): Exploring Valuation After Analyst Upgrade and Strong AI-Driven Results

Kshitija Bhandaru
EPAM Systems (NYSE:EPAM) is back in the spotlight after reporting quarterly results that beat forecasts, powered by strong demand for AI-focused services and digital modernization. The company also gave its outlook a lift, projecting annual revenue growth of 13% to 15%. Adding to the momentum, EPAM received an analyst upgrade to ‘Buy’, highlighting how three straight quarters of faster organic revenue and its completed post-Ukraine restructuring have changed the conversation for both...